Among the batch of grants recently approved by the Board was an HIV grant to Guyana. The proposed timeframe for the grant was 1 January 2018 to 31 December 2020. The principal recipient (PR) is the Ministry of Health, which also managed Guyana’s previous HIV grant.

Among the grants approved by the Board recently were four TB grants and one TB/HIV grant to India. In this article, we report on the comments from the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) on the funding request from which these grants emanated.

However, the TRP expressed concern about the absence of human rights- and gender-responsive programming

When it reviewed India’s HIV funding request in 2017, the Technical Review Panel (TRP) commended the Government of India for its ambitious plan to fast track the end of the HIV epidemic. At the same time, however, the TRP raised concerns about what it viewed as the request’s failure to include a focus on human rights and gender.

TRP suggests the country set up male health clinics where MSM could remain anonymous

The exchanges back and forth between Ethiopia’s country coordinating mechanism (CCM) and the Technical Review Panel (TRP) during the review of Ethiopia’s recent TB/HIV funding request illustrate just how hard it can be to make headway in providing services for men who have sex with men (MSM) and transgendered persons in a country where sexual activity between persons of the same sex is criminalized, and where stigma and discrimination toward M

When the Technical Review Panel (TRP) assessed Ethiopia’s TB/HIV funding request last Fall, it considered the request to be technically sound, but expressed concerns related to coverage of key populations.

The third batch of funding approvals by the Board (see GFO article) included two TB/HIV grants from Zambia. In this article, we report on the comments from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding requests from which these grants emanated.

Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.

Among the grants approved by the Board in December were HIV, TB/HIV and malaria grants for Burkina Faso. This article provides a summary of the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on all three grants.